| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a5c71dd251a59ebbfc1c7f8444f5a95d |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y02A50-30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2770-32351
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2770-32321
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2770-32332
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2333-085 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N7-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-5011
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-01
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K35-768
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K35-76 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-76 |
| filingDate |
2017-09-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_91dd322b92e21158fd02230a5f8e92f1
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_23a898d6d6d273edc2fb754c718ac79d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f783d2ee39398755de22722f9a951d8e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4674354544e9a79cea6aa5c386885802
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_596320a64a8f11a90f76937572a131b5
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e9272c666e8de1c92c565ee76b429b1a |
| publicationDate |
2019-04-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
AU-2017335673-A1 |
| titleOfInvention |
Optimized oncolytic viruses and uses thereof |
| abstract |
Methods of inhibiting or reducing tumor growth are disclosed. A composition containing at least one selected oncolytic virus is administered within a tumor of a patient. The virus kills cancerous cells and induces a systemic and lasting anti-tumor immunity that is also compatible with other cancer treatments. Also disclosed are methods of creating synthetic viruses for targeting cancerous tumors. |
| priorityDate |
2016-09-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |